In vitro, overexpression of TIM3 by CL4 CTL and treatment with an A2AR agonist inhibited killing of tumor cells in tumor spheroids and the A2AR agonist also reduced spheroid infiltration by CTL. The gene discussed is ADORA2A; the disease is neoplasm.